Published in Br J Cancer on December 18, 2007
Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 4.83
Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med (2013) 4.09
Selection criteria for lung-cancer screening. N Engl J Med (2013) 3.69
Predictive accuracy of the Liverpool Lung Project risk model for stratifying patients for computed tomography screening for lung cancer: a case-control and cohort validation study. Ann Intern Med (2012) 3.45
Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med (2011) 2.77
Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation. J Natl Cancer Inst (2011) 2.31
What characteristics of primary care and patients are associated with early death in patients with lung cancer in the UK? Thorax (2014) 2.26
Predicting lung cancer prior to surgical resection in patients with lung nodules. J Thorac Oncol (2014) 2.17
Lung carcinogenesis by tobacco smoke. Int J Cancer (2012) 2.06
An expanded risk prediction model for lung cancer. Cancer Prev Res (Phila) (2008) 2.05
Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 1.77
Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts. PLoS Med (2014) 1.73
Genetic risk prediction in complex disease. Hum Mol Genet (2011) 1.65
Development and validation of a lung cancer risk prediction model for African-Americans. Cancer Prev Res (Phila) (2008) 1.63
UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer. Thorax (2011) 1.62
Quantitative CT assessment of emphysema and airways in relation to lung cancer risk. Radiology (2011) 1.62
Regulatory approval of cancer risk-reducing (chemopreventive) drugs: moving what we have learned into the clinic. Cancer Prev Res (Phila) (2011) 1.62
Previous lung diseases and lung cancer risk: a systematic review and meta-analysis. PLoS One (2011) 1.62
Applying tobacco carcinogen and toxicant biomarkers in product regulation and cancer prevention. Chem Res Toxicol (2010) 1.58
A Perturbation Method for Inference on Regularized Regression Estimates. J Am Stat Assoc (2012) 1.53
Identifying patients with suspected lung cancer in primary care: derivation and validation of an algorithm. Br J Gen Pract (2011) 1.35
Lung cancer screening: the way forward. Br J Cancer (2008) 1.28
Eliciting symptoms interpreted as normal by patients with early-stage lung cancer: could GP elicitation of normalised symptoms reduce delay in diagnosis? Cross-sectional interview study. BMJ Open (2012) 1.27
Previous lung diseases and lung cancer risk: a pooled analysis from the International Lung Cancer Consortium. Am J Epidemiol (2012) 1.27
A clinical risk prediction model for Barrett esophagus. Cancer Prev Res (Phila) (2012) 1.21
Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women. Carcinogenesis (2009) 1.16
A test for genetic association that incorporates information about deviation from Hardy-Weinberg proportions in cases. Am J Hum Genet (2008) 1.12
Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement. Chest (2015) 1.11
Lung cancer risk in never-smokers: a population-based case-control study of epidemiologic risk factors. BMC Cancer (2010) 1.09
UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening. Thorax (2015) 1.08
Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial. J Clin Oncol (2013) 1.08
The effect of metformin and thiazolidinedione use on lung cancer in diabetics. BMC Cancer (2012) 1.08
Screening for lung cancer with low-dose computed tomography: a review of current status. J Thorac Dis (2013) 1.01
What proportion of lung cancer in never-smokers can be attributed to known risk factors? Int J Cancer (2012) 0.98
China national lung cancer screening guideline with low-dose computed tomography (2015 version). Thorac Cancer (2015) 0.96
An Official American Thoracic Society/American College of Chest Physicians Policy Statement: Implementation of Low-Dose Computed Tomography Lung Cancer Screening Programs in Clinical Practice. Am J Respir Crit Care Med (2015) 0.96
Bridging the clinical gaps: genetic, epigenetic and transcriptomic biomarkers for the early detection of lung cancer in the post-National Lung Screening Trial era. BMC Med (2013) 0.96
A risk model for lung cancer incidence. Cancer Prev Res (Phila) (2012) 0.95
Lung cancer screening: review and performance comparison under different risk scenarios. Lung (2013) 0.94
Comparison of discriminatory power and accuracy of three lung cancer risk models. Br J Cancer (2010) 0.94
Prediction of survival in resected non-small cell lung cancer using a protein expression-based risk model: implications for personalized chemoprevention and therapy. Clin Cancer Res (2013) 0.91
Comparing benefits from many possible computed tomography lung cancer screening programs: extrapolating from the National Lung Screening Trial using comparative modeling. PLoS One (2014) 0.90
Bridging the etiologic and prognostic outlooks in individualized assessment of absolute risk of an illness: application in lung cancer. Eur J Epidemiol (2016) 0.90
Prediction of lung cancer risk in a Chinese population using a multifactorial genetic model. BMC Med Genet (2012) 0.89
Individualized risk prediction model for lung cancer in Korean men. PLoS One (2013) 0.88
Chemoprevention of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 0.88
Lung cancer screening beyond low-dose computed tomography: the role of novel biomarkers. Lung (2014) 0.87
Lung cancer screening: identifying the high risk cohort. J Thorac Dis (2015) 0.86
Fifty years of tobacco carcinogenesis research: from mechanisms to early detection and prevention of lung cancer. Cancer Prev Res (Phila) (2014) 0.86
Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial. BMJ Open (2015) 0.85
Increased lung cancer risk among patients with pneumococcal pneumonia: a nationwide population-based cohort study. Lung (2013) 0.84
Trends in Subpopulations at High Risk for Lung Cancer. J Thorac Oncol (2016) 0.83
The cytokinesis-blocked micronucleus assay as a strong predictor of lung cancer: extension of a lung cancer risk prediction model. Cancer Epidemiol Biomarkers Prev (2014) 0.83
Demonstration program of population-based lung cancer screening in China: Rationale and study design. Thorac Cancer (2014) 0.83
Unique volatolomic signatures of TP53 and KRAS in lung cells. Br J Cancer (2014) 0.82
Risk Classification with an Adaptive Naive Bayes Kernel Machine Model. J Am Stat Assoc (2015) 0.82
Screening for lung cancer using low-dose computed tomography: concerns about the application in low-risk individuals. Transl Lung Cancer Res (2015) 0.80
The Lung Screen Uptake Trial (LSUT): protocol for a randomised controlled demonstration lung cancer screening pilot testing a targeted invitation strategy for high risk and 'hard-to-reach' patients. BMC Cancer (2016) 0.80
Updates and controversies in the rapidly evolving field of lung cancer screening, early detection, and chemoprevention. Cancers (Basel) (2014) 0.79
Clinical characteristics and prognosis of incidentally detected lung cancers. Int J Surg Oncol (2015) 0.78
Lung Cancer Risk Prediction Using Common SNPs Located in GWAS-Identified Susceptibility Regions. J Thorac Oncol (2015) 0.78
Biomarkers of risk to develop lung cancer in the new screening era. Ann Transl Med (2016) 0.78
Lung cancer risk test trial: study design, participant baseline characteristics, bronchoscopy safety, and establishment of a biospecimen repository. BMC Pulm Med (2016) 0.77
Lung cancer screening: past, present and future. Clin Chest Med (2013) 0.76
Cancer stem cell marker Musashi-1 rs2522137 genotype is associated with an increased risk of lung cancer. PLoS One (2014) 0.76
Occupational risk factors have to be considered in the definition of high-risk lung cancer populations. Br J Cancer (2012) 0.76
An ongoing case-control study to evaluate the NHS breast screening programme. BMC Cancer (2013) 0.76
Lung cancer screening: subsequent evidences of national lung screening trial. Tuberc Respir Dis (Seoul) (2014) 0.76
A simple model for predicting lung cancer occurrence in a lung cancer screening program: The Pittsburgh Predictor. Lung Cancer (2015) 0.75
Decision tree of occupational lung cancer using classification and regression analysis. Saf Health Work (2010) 0.75
A review of cancer risk prediction models with genetic variants. Cancer Inform (2014) 0.75
Soluble Human Epidermal Growth Factor Receptor 2 (sHER2) as a Potential Risk Assessment, Screening, and Diagnostic Biomarker of Lung Adenocarcinoma. Diagnostics (Basel) (2013) 0.75
Incorporating epistasis interaction of genetic susceptibility single nucleotide polymorphisms in a lung cancer risk prediction model. Int J Oncol (2016) 0.75
Combining Telomerase Reverse Transcriptase Genetic Variant rs2736100 with Epidemiologic Factors in the Prediction of Lung Cancer Susceptibility. J Cancer (2016) 0.75
Implementing lung cancer screening in the real world: opportunity, challenges and solutions. Transl Lung Cancer Res (2015) 0.75
Evaluating lung cancer screening in China: Implications for eligibility criteria design from a microsimulation modeling approach. PLoS One (2017) 0.75
Non-invasive lung cancer diagnosis by detection of GATA6 and NKX2-1 isoforms in exhaled breath condensate. EMBO Mol Med (2016) 0.75
Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study. PLoS Med (2017) 0.75
Molecular docking studies of Traditional Chinese Medicinal compounds against known protein targets to treat non-small cell lung carcinomas. Mol Med Rep (2016) 0.75
An Automated Method for Identifying Individuals with a Lung Nodule Can Be Feasibly Implemented Across Health Systems. EGEMS (Wash DC) (2016) 0.75
Small pulmonary nodules in baseline and incidence screening rounds of low-dose CT lung cancer screening. Transl Lung Cancer Res (2017) 0.75
Comparing the performance of trained radiographers against experienced radiologists in the UK lung cancer screening (UKLS) trial. Br J Radiol (2016) 0.75
Lung cancer screening with low-dose computed tomography. Radiol Clin North Am (2014) 0.75
Oral Cell DNA Adducts as Potential Biomarkers for Lung Cancer Susceptibility in Cigarette Smokers. Chem Res Toxicol (2016) 0.75
Mouse double minute-2 homolog (MDM2)-rs2279744 polymorphism associated with lung cancer risk in a Northeastern Chinese population. Thorac Cancer (2015) 0.75
Personalized Risk Assessment in Never, Light, and Heavy Smokers in a prospective cohort in Taiwan. Sci Rep (2016) 0.75
AURKA mRNA expression is an independent predictor of poor prognosis in patients with non-small cell lung cancer. Oncol Lett (2017) 0.75
[Lung cancer screening - risk stratification : Who should undergo screening?]. Radiologe (2016) 0.75
Risk assessment models for genetic risk predictors of lung cancer using two-stage replication for Asian and European populations. Oncotarget (2016) 0.75
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst (1989) 19.87
Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med (2006) 19.06
Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. J Epidemiol Community Health (1978) 7.80
Variations in lung cancer risk among smokers. J Natl Cancer Inst (2003) 5.00
Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. J Natl Cancer Inst (2006) 4.95
A risk model for prediction of lung cancer. J Natl Cancer Inst (2007) 4.25
Cancer risk prediction models: a workshop on development, evaluation, and application. J Natl Cancer Inst (2005) 3.75
When can a risk factor be used as a worthwhile screening test? BMJ (1999) 3.56
Occupational exposure to crystalline silica and risk of lung cancer: a multicenter case-control study in Europe. Epidemiology (2007) 2.60
Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force. Ann Intern Med (2004) 2.53
Lung cancer mortality in relation to age, duration of smoking, and daily cigarette consumption: results from Cancer Prevention Study II. Cancer Res (2003) 2.48
Lung cancer after radiation therapy for breast cancer. Cancer (1993) 1.68
Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA. Chest (2000) 1.64
Lung cancer risk prediction: a tool for early detection. Int J Cancer (2007) 1.51
Relationship between a history of antecedent cancer and the probability of malignancy for a solitary pulmonary nodule. Chest (2004) 1.34
Lung carcinoma in African Americans. Nat Clin Pract Oncol (2007) 1.33
The Liverpool Lung Project research protocol. Int J Oncol (2005) 1.23
Lung cancer risks in women with previous breast cancer. Eur J Cancer (2002) 1.19
The fallacy of enrolling only high-risk subjects in cancer prevention trials: is there a "free lunch"? BMC Med Res Methodol (2004) 1.11
Lung cancer screening by spiral CT. What is the optimal target population for screening trials? Lung Cancer (2002) 1.10
Family history and risk of lung cancer: age-at-diagnosis in cases and first-degree relatives. Br J Cancer (2006) 1.01
Previous cancer and radiotherapy as risk factors for lung cancer in lifetime nonsmokers. Cancer Causes Control (1993) 0.91
Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer (2001) 6.16
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. J Epidemiol Community Health (1989) 5.20
Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am (1992) 4.34
Breast cancer treatment and natural history: new insights from results of screening. Lancet (1992) 3.77
A novel method for prediction of long-term outcome of women with T1a, T1b, and 10-14 mm invasive breast cancers: a prospective study. Lancet (2000) 3.76
The natural history of breast carcinoma: what have we learned from screening? Cancer (1999) 3.55
Dietary effects on breast-cancer risk in Singapore. Lancet (1991) 3.32
Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial. Cancer (1995) 3.32
The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. Radiol Clin North Am (2000) 3.18
Methods in health service research. An introduction to bayesian methods in health technology assessment. BMJ (1999) 3.12
The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization. Cancer (1997) 2.75
Overdiagnosis in screening: is the increase in breast cancer incidence rates a cause for concern? J Med Screen (2004) 2.62
Age at first birth, parity and risk of breast cancer: a meta-analysis of 8 studies from the Nordic countries. Int J Cancer (1990) 2.61
Factors affecting morbidity and mortality after surgery for obstructive jaundice: a review of 373 patients. Gut (1983) 2.53
Early onset of breast cancer in a group of British black women. Br J Cancer (2008) 2.47
Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer (1995) 2.47
Polygenic susceptibility to prostate and breast cancer: implications for personalised screening. Br J Cancer (2011) 2.28
Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening. Eur J Cancer (2003) 2.26
Bayesian methods in health technology assessment: a review. Health Technol Assess (2000) 2.14
Occupational exposure to magnetic fields relative to mortality from brain tumours: updated and revised findings from a study of United Kingdom electricity generation and transmission workers, 1973-97. Occup Environ Med (2001) 2.08
Risk of hypospadias in relation to maternal occupational exposure to potential endocrine disrupting chemicals. Occup Environ Med (2003) 2.02
Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy. Br J Cancer (2009) 2.01
Infiltrating lobular carcinoma of the breast. Histopathology (1982) 1.98
Randomised controlled trial of educational package on management of menorrhagia in primary care: the Anglia menorrhagia education study. BMJ (1999) 1.96
Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial. Eur J Cancer (2013) 1.85
Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing. Br J Cancer (2006) 1.84
A case-control study to estimate the impact on breast cancer death of the breast screening programme in Wales. J Med Screen (2004) 1.81
A case-control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death. Acta Radiol (2007) 1.80
RadCon: phylogenetic tree comparison and consensus. Bioinformatics (2000) 1.79
Detection method, tumour size and node metastases in breast cancers diagnosed during a trial of breast cancer screening. Eur J Cancer Clin Oncol (1987) 1.79
Effect of breast cancer screening after age 65. J Med Screen (1995) 1.69
UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer. Thorax (2011) 1.62
Multi-state Markov models in cancer screening evaluation: a brief review and case study. Stat Methods Med Res (2010) 1.60
Pickled vegetables in the aetiology of oesophageal cancer in Hong Kong Chinese. Lancet (1992) 1.56
Comparison of single reading with double reading of mammograms, and change in effectiveness with experience. Br J Radiol (1995) 1.54
Estimating sensitivity and sojourn time in screening for colorectal cancer: a comparison of statistical approaches. Am J Epidemiol (1998) 1.54
Quantifying the risks of hypertension, age, sex and smoking in patients with abdominal aortic aneurysm. Br J Surg (2000) 1.51
Correction of risk estimates for measurement error in epidemiology. Methods Inf Med (1995) 1.50
Factors related to cervicitis in Qashghaee nomadic women of southern Iran. Rev Epidemiol Sante Publique (1997) 1.49
Modelling the analysis of breast cancer screening programmes: sensitivity, lead time and predictive value in the Florence District Programme (1975-1986). Int J Epidemiol (1991) 1.49
Nuclear isomers in superheavy elements as stepping stones towards the island of stability. Nature (2006) 1.48
Repeat measurement of case-control data: correcting risk estimates for misclassification due to regression dilution of lipids in transient ischemic attacks and minor ischemic strokes. Am J Epidemiol (1991) 1.47
Endoscopy assisted microthoracotomy: initial experience. Thorax (1992) 1.46
Colorectal cancer mass-screening: estimation of faecal occult blood test sensitivity, taking into account cancer mean sojourn time. Int J Cancer (1997) 1.46
Environmental tobacco smoke. Occup Environ Med (2004) 1.42
Breast cancer in Singapore: trends in incidence 1968-1992. Int J Epidemiol (1996) 1.41
Randomized clinical trial to determine the effect of nasogastric drainage on tracheal acid aspiration following oesophagectomy. Br J Surg (2006) 1.41
Major conceptual change required to improve lung cancer: see a respiratory physician. Eur Respir J (2003) 1.40
K-ras point mutation detection in lung cancer: comparison of two approaches to somatic mutation detection using ARMS allele-specific amplification. Clin Chem (2000) 1.40
A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive. Br J Surg (2008) 1.40
Socioeconomic effects on breast cancer survival: proportion attributable to stage and morphology. Br J Cancer (2003) 1.40
How should species phylogenies be inferred from sequence data? Syst Biol (1999) 1.37
Mean sojourn time, overdiagnosis, and reduction in advanced stage prostate cancer due to screening with PSA: implications of sojourn time on screening. Br J Cancer (2009) 1.36
Screen-detected vs symptomatic breast cancer: is improved survival due to stage migration alone? Br J Cancer (2008) 1.35
Estimation of sojourn time in chronic disease screening without data on interval cases. Biometrics (2000) 1.32
Number needed to screen: lives saved over 20 years of follow-up in mammographic screening. J Med Screen (2004) 1.31
Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol (2000) 1.30
Lung cancer screening: the way forward. Br J Cancer (2008) 1.28
Risk of breast cancer in relation to reproductive factors in Denmark. Br J Cancer (1988) 1.28
Risk factors for breast cancer by age and menopausal status: a case-control study in Singapore. Cancer Causes Control (1992) 1.27
Tumour development, histology and grade of breast cancers: prognosis and progression. Int J Cancer (1996) 1.26
Mammographic parenchymal patterns and risk of breast cancer at and after a prevalence screen in Singaporean women. Int J Epidemiol (2000) 1.25
How important is personal exposure assessment in the epidemiology of air pollutants? Occup Environ Med (2003) 1.25
Occupational exposure to magnetic fields in relation to mortality from brain cancer among electricity generation and transmission workers. Occup Environ Med (1997) 1.25
Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survival. Br J Cancer (2009) 1.23
Management of menorrhagia: an audit of practices in the Anglia menorrhagia education study. BMJ (2001) 1.23
Early detection of second breast cancers improves prognosis in breast cancer survivors. Ann Oncol (2009) 1.22
Molecular phylogenies and host-parasite cospeciation: gophers and lice as a model system. Philos Trans R Soc Lond B Biol Sci (1995) 1.20
A case-control study of the impact of the East Anglian breast screening programme on breast cancer mortality. Br J Cancer (2007) 1.20
Phylogenetic analysis of partial sequences of elongation factor 1alpha identifies major groups of lice (Insecta: Phthiraptera). Mol Phylogenet Evol (2001) 1.20
Respiratory health effects from exposure to carbon black: results of the phase 2 and 3 cross sectional studies in the European carbon black manufacturing industry. Occup Environ Med (2001) 1.20
Second-hand smoke levels in UK pubs and bars: do the English Public Health White Paper proposals go far enough? J Public Health (Oxf) (2006) 1.19
Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease. Br J Cancer (2010) 1.19
The long-term benefits of a single scan for abdominal aortic aneurysm (AAA) at age 65. Eur J Vasc Endovasc Surg (2001) 1.18
Allelotype analysis of oesophageal adenocarcinoma: loss of heterozygosity occurs at multiple sites. Br J Cancer (1998) 1.18
Quantification of the effect of mammographic screening on fatal breast cancers: The Florence Programme 1990-96. Br J Cancer (2002) 1.16
Serum regulation of the estrogen responsiveness of the human breast cancer cell line MCF-7. Cancer Res (1983) 1.15
A new era in the diagnosis of breast cancer. Surg Oncol Clin N Am (2000) 1.12
[Detection of cancer, sensitivity of the test and sensitivity of the screening program]. Rev Epidemiol Sante Publique (1998) 1.12
Excess cases of prostate cancer and estimated overdiagnosis associated with PSA testing in East Anglia. Br J Cancer (2006) 1.11
Preserved foods and nasopharyngeal carcinoma: a case-control study among Singapore Chinese. Int J Cancer (1994) 1.11
Evaluation of service screening mammography in practice: the impact on breast cancer mortality. Ann Oncol (2005) 1.11
Validation of a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma. Br J Cancer (2013) 1.10
Screening for breast cancer. Lancet (1995) 1.10
Stopping drinking and risk of oesophageal cancer. BMJ (1995) 1.10
Synchronous oral carcinomas: independent or common clonal origin? Cancer Res (1998) 1.10
Primary and adjuvant therapy, prognostic factors and survival in 1053 breast cancers diagnosed in a trial of mammography screening. Jpn J Clin Oncol (1999) 1.09
Randomization at the level of primary care practice: use of pre-intervention data and random effects models. Stat Med (2001) 1.09
Breast cancer: have we missed the forest because of the tree? Lancet (1994) 1.07
Risk factors for cancer of the buccal and labial mucosa in Kerala, southern India. J Epidemiol Community Health (1990) 1.07
Colorectal cancer and diet in an Asian population--a case-control study among Singapore Chinese. Int J Cancer (1989) 1.07
Mammographic density and its interaction with other breast cancer risk factors in an Asian population. Br J Cancer (2011) 1.07
The DNA damage checkpoint precedes activation of ARF in response to escalating oncogenic stress during tumorigenesis. Cell Death Differ (2013) 1.06
Alcoholism treatment with environmental support contracting. Am J Drug Alcohol Abuse (1984) 1.06
Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer. Ann Oncol (2012) 1.05
The prognosis of specific types of salivary gland tumors. Cancer (1984) 1.05